• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻使用对精神病超高危人群和健康对照者事件相关电位的影响。

Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls.

机构信息

Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

出版信息

Int J Psychophysiol. 2013 May;88(2):149-56. doi: 10.1016/j.ijpsycho.2013.03.012. Epub 2013 Mar 27.

DOI:10.1016/j.ijpsycho.2013.03.012
PMID:23541998
Abstract

Cannabis use has consistently been associated with psychotic symptoms as well as cognitive impairments. Moreover, its use may provoke subclinical psychotic symptoms and is associated with neuropsychological dysfunctions in subjects at ultra high risk (UHR) for developing psychosis. However, to our knowledge, no data are yet available on the relationship between cannabis use, UHR symptoms and information processing as assessed with event related potentials (ERP) in UHR subjects. This cross-sectional study therefore aimed to investigate N100, N200, P200 and P300 ERP components in 48 UHR subjects (19 cannabis users; UHR+C) and 50 healthy controls (21 cannabis users; HC+C). Results showed smaller P300 amplitudes in HC+C and UHR subjects compared to HC-C. Moreover, HC+C showed prolonged P300 and N200 latencies compared to HC-C and UHR-C. No significant ERP differences were found between UHR+C and UHR-C. Regarding the relationship between information processing and psychopathology, we found associations between ERP components and severity of UHR symptoms, findings being most pronounced for N100 latencies and P300 amplitudes and severity of general psychopathology and positive symptoms. We conclude that UHR subjects and healthy cannabis users demonstrate similar P300 amplitude reductions compared to non-using control subjects. In addition, the interrelation of cannabis use with prolonged ERP latencies may signify reduced information processing speed associated with cannabis use. Finally, our findings cautiously support the hypothesis that the clinical phenomena of the UHR state may be associated with abnormalities in stimulus processing.

摘要

大麻使用一直与精神病症状以及认知障碍有关。此外,大麻的使用可能会引发亚临床精神病症状,并与处于精神病发病极高风险(UHR)的受试者的神经心理学功能障碍有关。然而,据我们所知,目前尚无关于大麻使用、UHR 症状与 UHR 受试者用事件相关电位(ERP)评估的信息处理之间关系的数据。因此,这项横断面研究旨在调查 48 名 UHR 受试者(19 名大麻使用者;UHR+C)和 50 名健康对照者(21 名大麻使用者;HC+C)的 N100、N200、P200 和 P300 ERP 成分。结果显示,HC+C 和 UHR 受试者的 P300 振幅较小。此外,与 HC-C 相比,HC+C 和 UHR 受试者的 P300 和 N200 潜伏期延长。UHR+C 和 UHR-C 之间没有明显的 ERP 差异。关于信息处理和精神病理学之间的关系,我们发现 ERP 成分与 UHR 症状的严重程度之间存在关联,最明显的是 N100 潜伏期和 P300 振幅以及一般精神病理学和阳性症状的严重程度。我们得出结论,UHR 受试者和健康的大麻使用者与非使用者对照组相比,P300 振幅降低更为明显。此外,大麻使用与 ERP 潜伏期延长之间的相互关系可能表明与大麻使用相关的信息处理速度降低。最后,我们的研究结果谨慎地支持了这样一种假设,即 UHR 状态的临床现象可能与刺激处理异常有关。

相似文献

1
Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls.大麻使用对精神病超高危人群和健康对照者事件相关电位的影响。
Int J Psychophysiol. 2013 May;88(2):149-56. doi: 10.1016/j.ijpsycho.2013.03.012. Epub 2013 Mar 27.
2
Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.在极有可能发展为精神病的大麻使用受试者和健康对照者中,症状学和神经心理学功能。
Aust N Z J Psychiatry. 2010 Mar;44(3):230-6. doi: 10.3109/00048670903487118.
3
Auditory ERP components before and after transition to a first psychotic episode.首发精神病发作前后的听觉事件相关电位成分。
Biol Psychol. 2011 Jul;87(3):350-7. doi: 10.1016/j.biopsycho.2011.04.005. Epub 2011 Apr 30.
4
Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode.首次精神病发作前后处于超高风险发展为精神病的受试者的感觉门控。
World J Biol Psychiatry. 2015 Jan;16(1):12-21. doi: 10.3109/15622975.2012.680911. Epub 2012 Jun 26.
5
Auditory event-related potential of subjects with suspected pre-psychotic state and first-episode psychosis.疑似前驱期和首发精神病患者的听觉事件相关电位。
Schizophr Res. 2012 Sep;140(1-3):243-9. doi: 10.1016/j.schres.2012.06.021. Epub 2012 Jul 10.
6
Reduced visual P300 amplitudes in individuals at ultra-high risk for psychosis and first-episode schizophrenia.视觉 P300 振幅降低与精神病超高危个体和首发精神分裂症。
Neurosci Lett. 2010 Dec 17;486(3):156-60. doi: 10.1016/j.neulet.2010.09.035. Epub 2010 Sep 19.
7
Subjective effects of cannabis before the first psychotic episode.首发精神病性发作前大麻的主观效应。
Aust N Z J Psychiatry. 2009 Dec;43(12):1155-62. doi: 10.3109/00048670903179095.
8
N200 latency and P300 amplitude in depressed mood post-traumatic brain injury patients.创伤性脑损伤后情绪低落患者的N200潜伏期和P300波幅
Neuropsychol Rehabil. 2007 Dec;17(6):723-34. doi: 10.1080/09602010601082441.
9
Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis.超精神病高危个体对频率偏差的失匹配负波受损,且向精神病转化时进一步受损的初步证据。
Schizophr Res. 2018 Jan;191:95-100. doi: 10.1016/j.schres.2017.11.005. Epub 2017 Nov 11.
10
Auditory P300 and N100 components as intermediate phenotypes for psychotic disorder: familial liability and reliability.听觉 P300 和 N100 成分作为精神病障碍的中间表型:家族易感性和可靠性。
Clin Neurophysiol. 2011 Oct;122(10):1984-90. doi: 10.1016/j.clinph.2011.02.033. Epub 2011 Apr 1.

引用本文的文献

1
Influence of cannabis use on incidence of psychosis in people at clinical high risk.大麻使用对处于临床高风险的人群精神病发病的影响。
Psychiatry Clin Neurosci. 2023 Sep;77(9):469-477. doi: 10.1111/pcn.13555. Epub 2023 May 13.
2
Biomarkers and neuromodulation techniques in substance use disorders.物质使用障碍中的生物标志物与神经调节技术
Bioelectron Med. 2020 Feb 17;6:4. doi: 10.1186/s42234-020-0040-0. eCollection 2020.
3
Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review.临床精神病高危个体的大麻使用:全面综述。
Soc Psychiatry Psychiatr Epidemiol. 2020 May;55(5):527-537. doi: 10.1007/s00127-019-01810-x. Epub 2019 Dec 3.
4
Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.使用大麻和不使用大麻的患者是不同的群体吗? 旨在了解精神障碍患者中使用大麻的神经生物学。
J Psychopharmacol. 2018 Aug;32(8):825-849. doi: 10.1177/0269881118760662. Epub 2018 Mar 29.
5
Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta-analysis.精神病超高风险个体中使用大麻与症状严重程度:一项荟萃分析。
Acta Psychiatr Scand. 2017 Jul;136(1):5-15. doi: 10.1111/acps.12699. Epub 2017 Feb 7.
6
The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2.P300作为精神分裂症内表型和预测生物标志物的效用:COGS-2中的临床和社会人口学调节因素
Schizophr Res. 2015 Apr;163(1-3):53-62. doi: 10.1016/j.schres.2014.09.024. Epub 2014 Oct 11.